Evidence map›Paper›PMID 41035756›Full record

ArticleACS applied nano materials2025

Engineering the Colloidal Properties of Iron Oxide Nanoparticles for High

Samuel D Oberdick, Gabriella G Erich, Arabella R Stockdale, Kaitlyn M Betz, Kalina V Jordanova, Andrew G Korovich, O Thompson Mefford, Giacomo Parigi, Megan E Poorman, Gary Zabow and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied nano materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Samuel D OberdickDepartment of Physics, University of Colorado, Boulder, Colorado 80309, United States.ORCID https://orcid.org/0000-0003-4214-7492
Gabriella G ErichNational Institute of Standards and Technology, Boulder, Colorado 80305, United States.
Arabella R StockdaleDepartment of Materials Science and Engineering, Clemson University, Clemson, South Carolina 29634, United States.
Kaitlyn M BetzNational Institute of Standards and Technology, Boulder, Colorado 80305, United States.
Kalina V JordanovaNational Institute of Standards and Technology, Boulder, Colorado 80305, United States.
Andrew G KorovichNational Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States.
O Thompson MeffordDepartment of Materials Science and Engineering, Clemson University, Clemson, South Carolina 29634, United States.ORCID https://orcid.org/0000-0002-9164-2521
Giacomo ParigiMagnetic Resonance Center (CERM), University of Florence, via Luigi Sacconi 6, Sesto Fiorentino, Florence 50019, Italy.ORCID https://orcid.org/0000-0002-1989-4644
Megan E PoormanHyperfine, Inc. Guilford, Guilford, Connecticut 06437, United States.
Gary ZabowNational Institute of Standards and Technology, Boulder, Colorado 80305, United States.
Kathryn E KeenanNational Institute of Standards and Technology, Boulder, Colorado 80305, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-field magnetic resonance imaging (LF-MRI), an emerging form of portable and accessible MRI, has tremendous potential for point-of-care diagnostics and democratization of medical imaging. As LF-MRI evolves, there is a need to develop workflows, materials, and technologies designed specifically for the low-field regime. Here, monodisperse iron oxide nanoparticles (IONs) are evaluated for applications as positive contrast

Indexed as

contrast agentsiron oxide nanoparticlesmagnetic nanoparticlesmagnetic resonance imagingmedical imagingMRI contrast

Identifiers

PMID41035756
PMCPMC12481475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.